Glypican-3 (GPC3) signaling pathway involved in breast cancer progression

被引：0
|
作者：
Fernandez, Dolores [1 ]
Cercato, Magali [1 ]
Guereno, Macarena [1 ]
Peters, Maria G. [1 ]
机构：
[1] Angel H Roffo Inst Oncol, Buenos Aires, DF, Argentina
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-4508
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4508
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Role of Glypican-3 (GPC3) on tumor progression of the human mammary gland
    Castillo, Lilian F.
    Tascon, Rocio S.
    de Kier Joffe, Elisa Bal
    Peters, Maria G.
    CANCER RESEARCH, 2014, 74 (19)
  • [2] Significance of Glypican-3 (GPC3) Expression in Hepatocellular Cancer Diagnosis
    Sun, Bin
    Huang, Zhi
    Wang, Bi
    Yu, Yanglong
    Lin, Shihai
    Luo, Lei
    Wang, Yuzhu
    Huang, Zheng
    MEDICAL SCIENCE MONITOR, 2017, 23 : 850 - 855
  • [3] Expression of Glypican-3 (GPC3) in breast cancer tumors from Brazilian and Argentinean patients
    Lago Huvelle, Maria A.
    Maia, Aline
    Fujita, Andre
    Armanasco, Eduardo
    Bagnoli, Fabio
    de Oliveira, Vilmar Marques
    Longo Galvao Silva, Maria A.
    de Kier Joffe, Elisa Bal
    Sogayar, Mari C.
    Puricelli, Lydia
    Labriola, Leticia
    Peters, Maria G.
    CANCER RESEARCH, 2012, 72
  • [4] Glypican-3 (GPC3) inhibits metastatic dissemination in a preclinical human breast cancer model
    Castillo, Lilian F.
    Tascon, Rocio
    Bal de Kier Joffe, Elisa
    Peters, Maria G.
    CANCER RESEARCH, 2015, 75
  • [5] Glypican-3 (GPC3) inhibits the metastasis development in a murine breast cancer model through the activation of p38MAPK signaling pathway
    Tascon, Rocio S.
    Castillo, Lilian
    de Kier Joffe, Elisa Bal
    Peters, Maria G.
    CANCER RESEARCH, 2015, 75
  • [6] Glypican-3 (GPC3) induces a mesenchymal-epithelial transition in human breast cancer cells lines
    Castillo, Lilian F.
    Tascon, Rocio
    Joffe, Elisa Bal de Kier
    Peters, Giselle
    CANCER RESEARCH, 2016, 76
  • [7] An Assessment of the Heterogeneous Expression of Glypican-3 (GPC3) in Hepatocellular Carcinoma (HCC) in the Era of GPC3 as a Biomarker
    Cox, Brian
    Waters, Kevin
    Dhall, Deepti
    Larson, Brent
    Guindi, Maha
    LABORATORY INVESTIGATION, 2019, 99
  • [8] An Assessment of the Heterogeneous Expression of Glypican-3 (GPC3) in Hepatocellular Carcinoma (HCC) in the Era of GPC3 as a Biomarker
    Cox, Brian
    Waters, Kevin
    Dhall, Deepti
    Larson, Brent
    Guindi, Maha
    MODERN PATHOLOGY, 2019, 32
  • [9] Glypican-3 (GPC3) inhibits metastasis development promoting dormancy in breast cancer cells by p38 MAPK pathway activation
    Guereno, Macarena
    Delgado Pastore, Magali
    Clara Lugones, Ana
    Cercato, Magali
    Todaro, Laura
    Urtreger, Alejandro
    Giselle Peters, Maria
    EUROPEAN JOURNAL OF CELL BIOLOGY, 2020, 99 (06)
  • [10] Glypican-3 (GPC3) expression in hepatocellular carcinomas and preneoplastic liver lesions
    Xiao, X. Y.
    Dubois, S.
    Tessiore, S.
    Degos, F.
    Belghiti, J.
    Allegretta, M.
    Guttmann, R.
    Bedossa, P.
    Paradis, V.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S107 - S107
12345